Cost effectiveness of Daclatasvir/Asunaprevir versus Peginterferon/Ribavirin and protease inhibitors for the treatment of Hepatitis C genotype 1b naive patients in Chile
| dc.contributor.author | Vargas, Constanza L. | |
| dc.contributor.author | Espinoza SepĂșlveda, Manuel Antonio | |
| dc.contributor.author | Giglio, Andres | |
| dc.contributor.author | Soza, Alejandro | |
| dc.date.accessioned | 2020-08-21T23:15:58Z | |
| dc.date.available | 2020-08-21T23:15:58Z | |
| dc.date.issued | 2015 | |
| dc.fuente.origen | Converis | |
| dc.identifier.doi | 10.1371/journal.pone.0141660 | |
| dc.identifier.issn | 1932-6203 | |
| dc.identifier.uri | https://doi.org/10.1371/journal.pone.0141660 | |
| dc.identifier.uri | https://repositorio.uc.cl/handle/11534/40104 | |
| dc.identifier.wosid | WOS:000364398700038 | |
| dc.issue.numero | No. 11 | |
| dc.language.iso | en | |
| dc.nota.acceso | Contenido completo | |
| dc.pagina.final | 16 | |
| dc.pagina.inicio | 1 | |
| dc.revista | PLoS ONE | es_ES |
| dc.rights | acceso abierto | |
| dc.subject.ddc | 610 | |
| dc.subject.dewey | Medicina y salud | es_ES |
| dc.subject.ods | 03 Good health and well-being | |
| dc.subject.odspa | 03 Salud y bienestar | |
| dc.subject.other | Hepatitis C | es_ES |
| dc.subject.other | Hepatitis C - Terapia | es_ES |
| dc.subject.other | FarmacologĂa | es_ES |
| dc.title | Cost effectiveness of Daclatasvir/Asunaprevir versus Peginterferon/Ribavirin and protease inhibitors for the treatment of Hepatitis C genotype 1b naive patients in Chile | es_ES |
| dc.type | artĂculo | |
| dc.volumen | Vol. 10 | |
| sipa.codpersvinculados | 10720 | |
| sipa.codpersvinculados | 461 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Cost effectiveness of daclatasvir asunaprevir.pdf
- Size:
- 1.38 MB
- Format:
- Adobe Portable Document Format
- Description:
